Tarsus Pharmaceuticals, Inc.
TARS
Classement en actions
#4590
Tarsus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm... Tarsus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm dedicated to advancing and commercializing innovative therapies, primarily focusing on ocular conditions. Its leading investigational drug, TP-03, a novel treatment currently in Phase III trials, is being developed to address blepharitis specifically caused by Demodex mite infestations, as well as meibomian gland disease. Beyond this, Tarsus is also progressing TP-04 for rosacea and TP-05, which targets Lyme disease prevention and aims to reduce community-level malaria. A core element of its development strategy involves lotilaner, a compound utilized to tackle a variety of human diseases across diverse therapeutic areas, encompassing eye care, dermatology, and other medical fields. Established in 2016, the company maintains its headquarters in Irvine, California.
Prix de l'action
$71.12
Dernière synchronisation: 2026-10-20
Capitalisation boursière
$3.33B
Changement (1 jour)
2.33%
Changement (1 an)
0.42%
Pays
US
Échange Tarsus Pharmaceuticals, Inc. (TARS)
Catégorie
Healthcare
Nombre d'actions en circulation pour Tarsus Pharmaceuticals, Inc. (TARS)
Nombre d'actions en circulation au June 2026: 43.39M
Selon les derniers rapports financiers et le cours de l'action de Tarsus Pharmaceuticals, Inc., le nombre actuel d'actions en circulation est de 43.39M. À la fin de December 2023, l'entreprise avait 29.38M actions en circulation. Le nombre d'actions en circulation est généralement affecté par les divisions d'actions et les rachats d'actions.
Historique des actions en circulation de Tarsus Pharmaceuticals, Inc. (TARS) de 2018 à 2026
Actions en circulation à la fin de chaque année
| Année | Actions en circulation | Changez |
|---|---|---|
| 2026 (TTM) | 43.39M | 15.39% |
| 2024 | 37.60M | 27.98% |
| 2023 | 29.38M | 19.35% |
| 2022 | 24.62M | 19.78% |
| 2021 | 20.55M | 1.14% |
| 2020 | 20.32M | 4.17% |
| 2019 | 19.51M | 355.26% |
| 2018 | 4.29M | 0.00% |
Actions en circulation pour des entreprises similaires ou concurrentes
| Entreprise | Actions en circulation | Différence | Pays |
|---|---|---|---|
| 253.90M | 485.11% |
US
|
|
| 396.00M | 812.58% |
US
|
|
| 478.91M | 1,003.65% |
AU
|
|
| - | - |
CH
|
|
| 62.19M | 43.31% |
NL
|
